William (Bill) Allan Mercer

Bill Mercer joined the board following a 35 year career in blood banking, medical device and cellular therapy markets most recently serving as the Vice President—Automated Collections Business Area for TerumoBCT. His positions at Terumo BCT included several global appointments where he developed markets in Japan, China South East Asia, Australia and Canada. His expertise is in business strategy, new product/process development, commercialization and organizational effectiveness.  Mr. Mercer also spent seven years with TransBio (CRC for biomarker translation) as a Non-Executive Director in Melbourne, Australia, offering strategic guidance and corporate governance.  In this position, he was active in guiding investments of government research funds targeted at the use of novel proteins for cancer and inflammatory diseases.

In retirement, Mr. Mercer is focusing on expanding the effectiveness of medical device development and cell based therapeutics of an immunological, haematological and regenerative medicine nature. His passion is to deliver improved patient outcomes via increased access to and robustness of data and informatics within healthcare. He holds a BSc in Chemistry from the University of Western Ontario.